The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells

por Chen, M-C, Chen, C-H, Wang, J-C, Tsai, A-C, Liou, J-P, Pan, S-L, Teng, C-M
Publicado 2013

Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells

por Huang, H-L, Wu, H-Y, Chu, P-C, Lai, I-L, Huang, P-H, Kulp, S K, Pan, S-L, Teng, C-M, Chen, C-S
Publicado 2017

Correction: Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells

por Huang, H.-L., Wu, H.-Y., Chu, P.-C., Lai, I.-L., Huang, P.-H., Kulp, S. K., Pan, S.-L., Teng, C.-M., Chen, C.-S.
Publicado 2020

Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib

por Tsai, A-C, Wang, C-Y, Liou, J-P, Pai, H-C, Hsiao, C-J, Chang, J-Y, Wang, J-C, Teng, C-M, Pan, S-L
Publicado 2014